StockNews.com upgraded shares of Dr. Reddy’s Laboratories (NYSE:RDY – Get Rating) from a buy rating to a strong-buy rating in a research note released on Monday morning. Several other equities research analysts have also recently commented on RDY. JPMorgan Chase & Co. assumed coverage on shares of Dr. Reddy’s Laboratories in a research report on […]
Dr. Reddy’s Laboratories Limited (NYSE:RDY – Get Rating) has been given a consensus recommendation of “Hold” by the six research firms that are currently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a sell recommendation, two have issued a buy recommendation and one has issued a strong buy recommendation on […]
Dr. Reddy’s Laboratories Limited (NYSE:RDY – Get Rating) has been assigned an average recommendation of “Hold” from the six analysts that are covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, two have assigned a buy recommendation and one has issued a strong buy recommendation on the company. […]
James Investment Research Inc. purchased a new position in shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY – Get Rating) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 561 shares of the company’s stock, valued at approximately $29,000. Several other large investors also recently […]
Shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY – Get Rating) hit a new 52-week high on Wednesday . The stock traded as high as $60.28 and last traded at $60.23, with a volume of 23218 shares trading hands. The stock had previously closed at $58.74. Wall Street Analyst Weigh In Several analysts have commented on […]